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and lecithin chain length (Table II). A detailed model is
proposed to account for this behavior.
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ASSEMBLY OF THE PROTHROMBINASE COMPLEX
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The term "prothrombinase" refers to the complex
composed of the enzyme Factor Xa, the cofactor protein
Factor Va, calcium ions and phospholipid, which is
thought to be responsible for the physiological conversion
of the zymogen prothrombin to the enzyme thrombin.
Although Factor Xa is sufficient for prothrombin activa-
tion, the cofactors increase the rate of thrombin generation
- 300,000-fold at plasma concentrations of enzyme and
substrate. Both the enzyme (Factor Xa) and the substrate
(prothrombin) of this reaction are vitamin K-dependent
proteins, each of which possesses y-carboxyglutamic acids
at the NH2 terminals of their respective peptide chains. As
a consequence of these residues, these proteins can, in the
presence of calcium, bind membranes containing acidic
phospholipids. The cofactor for the reaction, Factor Va, is
present in plasma in the form of a "pro" cofactor species,
Factor V. Limited proteolysis by thrombin converts the
"pro" cofactor, Factor V, to the active cofactor, Factor Va.
Current data suggest that Factor V possesses some mini-
mal level of activity, but that Factor Va is at least 400
times more active than the uncleaved Factor V.
The "pro" cofactor species, Factor V, is a rather
unusual plasma protein. It is a single-chain protein with a
molecular weight of 330,000 (1). Both sedimentation and
gel filtration analysis of Factor V suggest that the protein
is highly asymmetric. The sedimentation coefficient for
Factor V is - 9.2S and the Stokes Radius is 91-93 A (1,
2). Factor V possesses three binding sites for calcium, two
having dissociation constants of 6 x 10-5M, one of
< 10-8M (3). This very tightly-bound calcium appears to
have structural significance with respect to the ultimate
association of Factor Va polypeptide chains. Thrombin
cleaves Factor V at at least four points in the polypeptide
chain, leading to a Factor Va molecule composed of two to
three peptide units. Two peptides with molecular weights
of 94,000 and 74,000 are essential for the cofactor activity
present in Factor Va preparations (3, 4). A third peptide,
with a molecular weight 31,000, is also associated with the
Factor Va molecule, while two activation peptides with
apparent molecular weights 70,000 and 90,000 are not
associated with Factor Va. The treatment of Factor Va
with EDTA permits dissociation of the two essential
Factor Va chains (94,000 and 74,000), neither of which
possesses activity in its own right (5, 6). These chains can
be reassociated by the readdition of calcium ion. The
functions of the remaining polypeptide chains in Factor Va
have not yet been investigated. The Stokes Radius
obtained on gel filtration of Factor Va is - 51 A (2).
Both Factor V and Factor Va bind to phosphatidylchol-
ine-phosphatidylserine vesicles and to blood platelets (7,
8). In contrast to the vitamin K-dependent proteins, Factor
V binding to membranes is metal ion and ionic strength
independent. The activated cofactor binds to acidic phos-
pholipid-containing vesicles with approximately ten times
the affinity of either prothrombin or Factor Xa, and binds
to a limited number of sites on the platelet membranes
with a dissociation constant of 10-°0 M.
RESULTS AND DISCUSSION
We are examining the participation of each of the three
proteins, phospholipid and platelet membranes, and
calcium ions in the generation of thrombin from prothrom-
bin. Our approaches include equilibrium binding measure-
ments of each of the species in the reaction system, using
light scattering, fluorescence, and sedimentation tech-
niques, and studies of the conversion of prothrombin to
thrombin using both a synthetic substrate and prothrom-
'bin (9). In the latter case, the fluorescent inhibitor, dansy-
larginine N-(3-ethyl-1,5-pentanediyl)amide (DAPA) has
been used as a probe. This compound is a specific inhibitor
of thrombin (Kd = 4 x 10-8M) and binds reversibly at the
active site in 1:1 stoichiometry (10). The bound probe
exhibits fluorescence properties allowing for continuous
assessment of the formation of thrombin from a zymogen
prothrombin.
In addition to equilibrium studies of biomolecular
association processes, we have recently extended our stud-
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FIGURE 1 Model of the activation of prothrombin as catalyzed by the
prothrombinase complex. (From reference 6).
ies to more complex interaction systems, using doubly
labeled radioactive probes in studies of platelet binding
(11). We have also recently been able to develop (in
conjunction with Drs. Elliott Shaw and Charles Kettner) a
useful fluorescent Factor Xa derivative which is labeled at
the active site histidine with a fluorescent peptide chlorom-
ethylketone, dansylglutamylglycylarginine chloromethyl-
ketone (12).
The results of studies completed thus far indicate that
the substrate (prothrombin) is not an intrinsic component
in the formation of the complex catalyst. Factor Va
functions, in part, by partitioning Factor Xa to the surface
of the phospholipid vesicle or to the platelet membrane
surface. Using the composite of kinetic and equilibrium
data, we can model the rate enhancement observed for
prothrombinase in terms of partitioning of substrate and
enzyme to the vesicle surface, enhanced by the catalytic
efficiency of Factor Xa.
A model expressing our working hypothesis is presented
in Fig. 1. The curved surface denotes a section of a
phospholipid vesicle. A molecule of Factor Va is embedded
in the lipid surface and is in 1:1 stoichiometry with Factor
Xa. Activation of the cofactor through proteolytic cleav-
age is suggested by a fissure in the model. Molecules of
prothrombin, with the prothrombin fragment- 1, prothrom-
bin fragment-2, and prethrombin-2 domains, are shown
both in solution and on the vesicle surface. Binding of
prothrombin to the phospholipid is suggested through
Ca"+ bridging mediated by the y-carboxyglutamate resi-
dues of the fragment-i domain. The interaction of Factor
Va with prothrombin through the fragment-2 domain is
also shown in accordance with inferences drawn previously
from studies of prothrombin activation. Prothrombinase is
composed of a phospholipid-bound complex of Factor Va
and Factor Xa, with Ca"+ participating in many of the
interactions required in the assembly of the catalyst. In
this model, Factor Va provides the "binding site" for
Factor Xa.
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